Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids

BACKGROUND: Systemic therapy is the primary treatment for advanced thymic malignancies. However, there is an urgent need to improve clinical outcome. Personalized treatment based on predictive biomarkers is a potential approach to address this requirement. In this study, we aimed to show the correla...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuan‐Hung, Chao, Heng‐sheng, Chiang, Chi‐Lu, Luo, Yung‐Hung, Chiu, Chao‐Hua, Yen, Sang‐Hue, Liu, Chun‐Yu, Chiou, Jeng‐Fong, Burnouf, Thierry, Chen, Yin‐Ju, Wang, Peng‐Yuan, Chao, Tsu‐Yi, Hsu, Shih‐Ming, Lu, Long‐Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481139/
https://www.ncbi.nlm.nih.gov/pubmed/37474689
http://dx.doi.org/10.1111/1759-7714.15039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481139/
https://www.ncbi.nlm.nih.gov/pubmed/37474689
http://dx.doi.org/10.1111/1759-7714.15039

Ejemplares similares